Your shopping cart is currently empty

NBI-6024, an altered peptide ligand (APL), acts as an epitope for interferon-gamma-producing T helper lymphocytes linked to inflammation in type 1 diabetes patients [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | NBI-6024, an altered peptide ligand (APL), acts as an epitope for interferon-gamma-producing T helper lymphocytes linked to inflammation in type 1 diabetes patients [1] [2]. |
| In vivo | NBI-6024, administered subcutaneously at doses ranging from 0.005 to 20 mg/kg, slows the progression and decreases the occurrence of diabetes in mice [2]. |
| Molecular Weight | 1521.72 |
| Formula | C66H112N20O21 |
| Cas No. | 239480-61-6 |
| Smiles | [C@H](CC1=CN=CN1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(NCC(O)=O)=O)CCCNC(=N)N)=O)CCC(O)=O)=O)=O)C)=O)C(C)C)=O)CC(C)C)=O)C)=O)CC(C)C)=O)C)=O)CCC(O)=O)=O)C(C)C)=O)CC(C)C)=O)NC([C@H](CO)N)=O |
| Sequence | H-Ser-His-Leu-Val-Glu-Ala-Leu-Ala-Leu-Val-Ala-Gly-Glu-Arg-Gly-OH |
| Sequence Short | SHLVEALALVAGERG |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.